Gagandeep Kang awarded Fellowship of the Royal Society (FRS), UK

Gagandeep Kang becomes first Indian woman scientist to be awarded Fellowship of the Royal Society (FRS), United Kingdom.

Gagandeep Kang

  • She is a clinician scientist, who is well known for her key role in development of Rotavac. She currently appointed as executive director of Translational Health Science and Technology Institute (THSTI), Faridabad, which is an autonomous institute of Department of Biotechnology, Ministry of Science and Technology.
  • In 2016, she was conferred prestigious Infosys Prize in Life Sciences for her contributions in understanding natural history of rotavirus and other infectious diseases.
  • She is also first Indian and first woman to edit Manson’s Textbook of Tropical Medicine.

Rotavac

It is India’s first indigenously developed vaccine for rotavirus infections, which is responsible for childhood diarrhea. The Rotavac was developed by Hyderabad-based Bharat Biotech Limited and Pune-based Serum International also developed a rotavirus vaccine called Rabishield. Both of them are included in India’s Immunisation Programme.

In January 2018, World Health Organisation (WHO) “pre-qualified” the Rotavac vaccine, which means that vaccine could be sold internationally to other countries in Africa and South America.

Fellowship of the Royal Society

It is the oldest scientific academy in continuous existence since 1663. It is an award sponsored by Royal Society of London and also known as FRS, ForMemRS and HonFRS. It is granted to individuals who made substantial contribution to improvement of natural knowledge in fields of natural knowledge, including mathematics, engineering science, and medical science.

It has been awarded to many eminent scientists approximately 8000 in total with 1675 living right now, including Isaac Newton, Charles Darwin, Michael Faraday, Ernest Rutherford, Srinivasa Ramanujan, Albert Einstein, Winston Churchill etc.

Watch A Video on our Channel

Advertisement

Month:

Categories: Awards & Honours

Tags:

advertisement

Comments